Overview

  • Product name
    Anti-NOTCH3 antibody [NIZ 8G5]
    See all NOTCH3 primary antibodies
  • Description
    Rat monoclonal [NIZ 8G5] to NOTCH3
  • Tested applications
    Suitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat
  • Immunogen

    Recombinant full length protein corresponding to Human NOTCH3 aa 1-2321.
    Database link: Q9UM47

  • Positive control
    • T47D or Jurkat cell extract

Properties

Applications

Our Abpromise guarantee covers the use of ab213632 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 2 - 4 µg/ml. Predicted molecular weight: 244 kDa.

Target

  • Function
    Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs.
  • Tissue specificity
    Ubiquitously expressed in fetal and adult tissues.
  • Involvement in disease
    Defects in NOTCH3 are the cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310]. CADASIL causes a type of stroke and dementia of which key features include recurrent subcortical ischemic events and vascular dementia. The disorder affects relatively young adults of both sexes. Mutations affect highly conserved cysteine residues within epidermal growth factor (EGF)-like repeat domains in the extracellular part of the receptor.
  • Sequence similarities
    Belongs to the NOTCH family.
    Contains 5 ANK repeats.
    Contains 34 EGF-like domains.
    Contains 3 LNR (Lin/Notch) repeats.
  • Post-translational
    modifications
    Synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase in the trans-Golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form. Cleavage results in a C-terminal fragment N(TM) and a N-terminal fragment N(EC). Following ligand binding, it is cleaved by TNF-alpha converting enzyme (TACE) to yield a membrane-associated intermediate fragment called notch extracellular truncation (NEXT). This fragment is then cleaved by presenilin dependent gamma-secretase to release a notch-derived peptide containing the intracellular domain (NICD) from the membrane.
    Phosphorylated.
  • Cellular localization
    Cell membrane and Nucleus. Following proteolytical processing NICD is translocated to the nucleus.
  • Information by UniProt
  • Database links
  • Alternative names
    • CADASIL antibody
    • CASIL antibody
    • NOTC3_HUMAN antibody
    • Notch 3 antibody
    • Notch 3 intracellular domain antibody
    • Notch homolog 3 antibody
    • Notch3 antibody
    see all

Images

  • All lanes : Anti-NOTCH3 antibody [NIZ 8G5] (ab213632) at 0.5 µg/ml

    Lane 1 : T47D cell extract
    Lane 2 : Jurkat cell extract

    Secondary
    Rabbit Anti-Rat IgG-Peroxidase

    Predicted band size : 244 kDa

References

ab213632 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab213632.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up